Company

People

Led by Science. Inspired by People

We believe neDNA™, the enzymatic DNA manufactured at TAAV, is paving the way to a new era of gene therapy development. This technology offers an alternative to plasmids for rAAV manufacturing and is designed to transform and accelerate the traditional gene therapy development timelines.

This innovation can only be made possible through the power of science. However, science needs great minds and dedicated hands; science needs passionate people committed to change. 

We aim to change patients’ lives. This is what inspires us.

More about neDNA™: Enzymatic DNA Manufacturing. 

Leadership

TAAV’s Leadership team is composed of strong, dedicated and qualified professionals focused on driving your rAAV programs to success. Get to know our global management team who guides and inspires our people to deliver exceptional results for our customers bringing a wealth of development, manufacturing and commercial experience from leading life sciences companies.

Jimmy Vanhove

General Manager

Jimmy Vanhove

Jimmy Vanhove brings extensive experience in strategy, operational management, and digital transformation in the biotech/pharma industry. He has held various leadership positions with increased responsibility in manufacturing and strategy consulting at multinational companies like GSK Vaccines, Bayer, and Roland Berger. Before joining Viralgen in 2021, he worked as the chief of staff for Bayer Pharma Product Supply. Jimmy holds a master’s degree in Bioscience Engineering from KU Leuven, and in General Management from Vlerick Business School. He has also received executive training in Digital Transformation at IMD, Lausanne, and Executive Management Development at IESE business school, Barcelona.

Félix Bastida, PhD

Scientific Director

Félix Bastida, PhD

Graduated in Veterinary Medicine from the University of Zaragoza and Doctor in Veterinary Medicine from Cornell University (USA), he is an expert in the management of research and development projects and the implementation of biotechnological start-ups. He has specialized in molecular biology, development and commercial production of diagnostic kits (PCR, ELISA), immunology, and virulence factors and pathogenesis of microorganisms. Throughout his career, he has held various positions as a researcher at US universities -Cornell, California-San Diego and Los Angeles- and senior executive and managerial responsibilities in biotechnology companies. He has been Development Director of ArtiVent Innovative Therapies S.L., Research Director of Vacunek S.L. and General Director of the UTE Vacunek-CZV Veterinaria.

Sergio Martín

Director of Engineering

Sergio Martín

Graduated in Industrial Engineering by the University of Navarra (Spain). He has more than 20 years of experience designing, building and maintenance of facilities for different industrial sectors, especially in healthcare. Also with experience as Industrial Plant Efficiency Auditor and BIM MEP design. Since 2013 Associate Professor of Industrial Facilities on the Master of Industrial Engineering of the University of Navarra (Tecnun). Sergio has joined TAAV in March 2020 where he currently works as Director of Engineering.

María Dolores Gálvez, PhD

Program Management Director

María Dolores Gálvez, PhD

Graduated in Biology from the University of Navarra (Spain) and Doctor in Biology from the Public University of Navarra (Spain) with research stay at the Utrecht University (The Netherlands) and pre-doctoral stay at the University of Nebraska-Lincoln (USA). PMP® certified by the Project Management Institute. As a researcher, she focused on the study of genetic markers for the differential diagnosis of mental disorders in the Clinic University of Navarra (Spain), funded by the Alicia Koplowitz Foundation. She has worked for 12 years at 3P Biopharmaceuticals holding responsibility positions in Upstream, Planning and Logistics and Project Management. She has extensive experience in recombinant proteins and monoclonal antibodies.

Lara Pascual

Financial Director

Lara Pascual

Graduate in Economy and Business Management, Master in International Management, Financial Audit and Management Development by Universidad de Deusto (Spain). With wide experience in financial auditing in different industrial sectors and several years in Financial Department of a multi-national firm, Lara has joined TAAV in 2019 where she currently works as responsible of company financial management.

Jaime Vaquerizo

Director of Quality

Jaime Vaquerizo

Degree in Biochemistry from the University of the Basque Country and Master's Degree in Research, Development and Innovation of Medicines from the University of Navarra. He has been a Quality Assurance Technician at the Center for Research in Applied Pharmacobiology (CIFA) and Director of Quality Assurance and Quality Control at 3P Biopharmaceuticals. He is an expert in quality management, GMP regulations and the design, construction and qualification of biotechnology companies, as well as in the implementation of GXP quality systems and regulatory standards.

Martín Julian Salellas

Biomanufacturing Director

Martín Julian Salellas

Lucía San Miguel

Quality Senior Manager

Lucía San Miguel

Graduated in Pharmacy and Master's Degree in Research, Development and Innovation of Medicines from the University of Navarra (Spain). She has served in TAAV as Quality Senior Manager since 2019. She worked for 11 years in Quality Assurance and Quality Control fields in the CDMO biotech industry, including positions as Analytical Services Director and Qualified Person. She has expertise in the implementation and maintenance of Quality Management Systems, in GMP regulations, in the design, construction and qualification of biotechnology companies, as well as in the management of human teams and resources.

 

Leticia Agúndez, PhD

R&D Senior Manager

Leticia Agúndez

Leticia graduated with a bachelor’s degree in Biochemistry from the University of the Basque Country (Spain) and obtained a PhD in Molecular Microbiology from the University of Cantabria (Spain). During her post-doctoral research work at King’s College London (KCL), she focused her studies on AAV biology. Later, at University College London (UCL), she worked on gene editing and gene and cell therapies for the treatment of retinal disorders. With more than 15 years of experience in basic and translational research, she is an expert in the fields of molecular biology, AAV and gene therapies. Since August 2019, Leticia leads the R&D department at TAAV.

Sergio Cuesta

Manufacturing Senior Manager

Sergio Cuesta

Graduated in Biotechnology from the Valencia Polytechnic University (Spain) and Master’s degree in Health Science Research from the Public University of Navarre (Spain). Throughout his career, Sergio has specialized in the biomedical field and specifically in molecular biology and genetic engineering of human pathogens and the study of virulence factors and pathogenesis. He has worked as a researcher at different groups at the Spanish National Research Council (CSIC) where he developed strong organizational and leadership skills. Sergio joined TAAV in 2020 and currently leads the areas of neDNA™ production and manufacturing process improvements.

Shalom Pérez

Human Resources Senior Manager & Head of Compliance

Shalom Pérez

Bachelor’s degree in business administration from the Steinbeis Hoschule in Berlin (Germany). Shalom brings more than 20 years in Human Resources working with companies in different industries and countries, such as Siemens in Mexico, Latin-American and Germany and Woco Automotive Group in Germany and Spain. She joined TAAV in June 2022 where she now heads the implementation and standardization of all human resources matters and compliance system aligning them to AskBio Inc. and Bayer Group Policies.

 

Cecilia Folio: TAAV neDNA Enzymatic DNA Manufacturing Project Manager

Cecilia Folio, PhD

Senior Project Manager

Cecilia Folio, PhD

Graduated in Pharmacy and Doctor in Cellular and Molecular Biology from the University of Navarra (Spain) with a pre-doctoral internship at King's College London-Guys Hospital (UK). The main focus of her post-doctoral research work at the University of Oxford was to gain a greater understanding of how homologous recombination (HR) helps prevent genomic instability, the underlying mechanism of many cancers. Analytical and highly qualified medical sciences professional with extensive experience in research and development, program management, and clinical analysis. She has also an International MBA from the EAE Business School and large experience in Project Management in biotechnological companies. Cecilia joint TAAV in 2021 and since then she has occupied the role of Project Manager. In April 2023 she was promoted to Senior Project Manager leading the PM team

Join Us

If you are passionate about innovation, science and improving people’s lives, you will be a perfect fit to our team of more than 80 enthusiastic and brilliant minds.

Come join our team of experts. Together, we have the power to make it happen.

Happy Holidays 2023